| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO And President
7 companies
Bailey Jeffrey Allen is a Director at Rein Therapeutics, Inc. with holdings across 7 companies. Recent SEC Form 4 filings include 7 buys and 1 sell.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sale+OE | 4,557 | $8.43 | $38,415.51 | -25.4% | -6.1% | +84.7% | |
| Sep 23, 2020 | THQ Abrdn Healthcare Opportunities Fund | Director | Buy | 570 | $17.68 | $10,077.60 | New | - | - | |
| Sep 23, 2020 | THW Abrdn World Healthcare Fund | Director | Buy | 710 | $14.18 | $10,067.80 | New | - | - | |
| Sep 23, 2020 | HQH Abrdn Healthcare Investors | Director | Buy | 490 | $20.39 | $9,991.10 | New | - | - | |
| Sep 22, 2020 | HQL Abrdn Life Sciences Investors | Director | Buy | 580 | $17.28 | $10,022.40 | New | - | - | |
| Nov 15, 2019 | RNTX Rein Therapeutics, Inc. | Director | Buy | 55,000 | $0.51 | $28,050.00 | +98.8% | - | - | |
| Nov 12, 2019 | RNTX Rein Therapeutics, Inc. | Director | Buy | 19,894 | $0.53 | $10,543.82 | New | - | - |